AREVA
AREVA
Anticoagulation et REmplacement VAIvulaire. A trial comparing moderate to usual anticoagulation in patients with mechanical valve prostheses who are at increased risk of thromboembolism.Conclusion Haemorrhagic events occurred in 34 ≤3.0-INR patients and 56 ≥3.0-INR patients (p <.01 and="" events.="" haemorrhagic="" major="" vs="">